ZFYVE1 Activators
ZFYVE1 Activators are a defined set of chemical compounds that enhance the activity of ZFYVE1 through various intracellular pathways and processes. Forskolin, by increasing cAMP levels, indirectly augments ZFYVE1's role in endosomal trafficking through activation of PKA, which may phosphorylate and activate proteins involved in the same pathway as ZFYVE1. Similarly, EGCG, operating as a kinase inhibitor, can diminish competitive signaling interference, indirectly facilitating ZFYVE1's functions in endosome-related processes. Ionomycin, through its elevation of intracellular calcium, could enhance calcium-dependent phosphorylation, which is key to ZFYVE1's role in endocytosis. On another front, sphingosine-1-phosphate, a bioactive lipid, is thought to boost lipid signaling pathways critical to ZFYVE1's operations, thus potentiating its function in trafficking.
The activity of ZFYVE1 is further supported by compounds like PMA, which activates PKC and may lead to downstream signaling that enhances ZFYVE1-mediated endocytic pathways. Brefeldin A's disruption to Golgi-endosome trafficking could lead to an indirect upregulation of ZFYVE1 activity to maintain cellular trafficking functions. NSC23766, by inhibiting Rac1, may indirectly amplify ZFYVE1's endocytic functions by reducing competition from Rac1-mediated pathways. Lastly, Go6976 and Bisindolylmaleimide I, both selective PKC inhibitors, suggest a mechanism where the reduced activity of certain PKC isoforms could lead to a relative increase in ZFYVE1-mediated endocytic activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which activates PKA. PKA can phosphorylate ZFYVE1, enhancing its role in endosomal signaling and trafficking. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may reduce competitive signaling, indirectly promoting ZFYVE1's function in lipid-mediated endosomal trafficking by reducing kinase-based inhibition. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can promote calcium-dependent phosphorylation processes, indirectly amplifying ZFYVE1's role in calcium-regulated endocytosis. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
As a lipid signaling molecule, sphingosine-1-phosphate may enhance the lipid signaling pathways that ZFYVE1 is involved in, promoting its function in endosomal trafficking. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PKC, which can lead to downstream effects that enhance ZFYVE1's activity in endocytic pathway regulation. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi-endosome trafficking, which could lead to a compensatory enhancement of ZFYVE1 activity to maintain endosomal functions. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
As an inhibitor of Rac1, NSC23766 might indirectly increase ZFYVE1 activity by reducing Rac1-mediated endocytic trafficking, potentially enhancing alternate routes involving ZFYVE1. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 is a PKC inhibitor, which by inhibiting certain PKC isoforms, might indirectly increase ZFYVE1-mediated endocytic processes. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a selective PKC inhibitor that could enhance ZFYVE1's role in endocytic trafficking by indirectly influencing the signaling pathways that regulate this process. | ||||||